Forbion portfolio company Purespring Therapeutics, a pioneering company focused on transforming the treatment of kidney diseases, announces the appointment of Haseeb Ahmad as its Chief Executive Officer and member of the Board of Directors. He brings significant senior industry leadership, joining Purespring with over 25 years in the life sciences industry and an impressive track record of leading organisations to create blockbuster brands from primary care to rare diseases, across both mature and growth markets. Click on the following link to learn more: https://lnkd.in/e9VWsrce #lifesciences #portfoliocompany #news #appointment #venturecapital
Chief Executive Officer at Purespring Therapeutics
2wGreat to be onboard and work with the talented Purespring Team and to offer real promise for the kidney disease patient community!